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Abstract Patients with chronic migraine developing
medication-overuse headache (MOH) show dependency-
like behaviors such as loss of control over analgesics
despite adverse consequences on headaches, high rates
of relapse after withdrawal from symptomatic medica-
tions, and compromised social functioning. Neuroimaging
research suggests a common pathophysiology between
substance-use disorders and MOH, which involves func-
tional alterations in fronto-striatal networks, particularly in
the orbitofrontal region of prefrontal cortex. These findings
could explain the impaired decision-making observed in
substance-use disorders. We hypothesize that MOH could
share fronto-striatal circuit dysfunction and relative deci-
sion-making deficit with addiction. We further examine
whether this deficit is a persistent cognitive trait or a
reversible consequence of medication overuse. This study
shows a dataset of 50 patients with MOH before the
detoxification. All patients underwent a complete neuro-
logical and psychiatric examination. Psychiatric exami-
nation consisted of a clinical interview, Structured
Clinical Interview for DSM-IV TR Axis II Personality
Disorders, Anxiety and Depression Hamilton Scales,
Severity of Dependence Scale. The neurological examination
included the migraine disability assessment questionnaire.
Neuropsychological assessment of fronto-striatal circuits
was investigated using the Iowa gambling task (IGT).
Twenty patients monitored for any relapse into medication
overuse had 12 months of follow-up. Our sample, char-
acterized by high rates of disability and dependency-like
behaviors, exhibited a deficit in IGT performance, indi-
cating an overall impairment in decision-making. All the
20 patients showed neurological and psychiatric improve-
ment at 12-month follow-up, notwithstanding the overuse
relapse, but a persistent IGT deficit was found. To our
knowledge this is the first study that assesses this cognitive
function in patients with MOH. Medication-overuse
headache seems to share a persistent decision-making
deficit with substance abuse that confirms the orbitofrontal
cortex hypometabolism described in literature from a
neuropsychological perspective. Looking at these shared
neurocognitive features, our results suggest that MOH
could belong to the addiction spectrum. Fronto-striatal
dysfunction could be a premorbid psychobiological con-
dition of vulnerability explaining the clinical onset of
medication overuse and recurrent relapses. We propose
that IGT could be used to identify chronic migraine
patients with higher risk for medication overuse and
relapse.
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Introduction
From 30 to 50 % of chronic migraineurs who, during the
natural history of their disease, experience an increase of
episode frequency and intensity, start overusing symp-
tomatic drugs for migraine in order to cope with pain and
disability. They enter a vicious cycle where overuse of
medications no longer controls headaches and becomes
responsible of the onset of a secondary headache with
variable clinical features, called medication-overuse head-
ache (MOH) [1, 2].
Beyond the necessity of coping with the increased pain
and disability, some dependency-like behaviors are being
pointed out as possible reasons for medication overuse
[3–5]. Loss of control over the use of painkillers despite the
adverse consequences on headaches (unmanageability) and
high rates of relapse (powerlessness) occur in a high pro-
portion of patients (30–40 % at 1 year, 40–70 % after
4–5 years) [2]. Pharmacological tolerance, cephalalgia-
phobia, high rates of disability and compromised social
functioning are often observed in these patients. Taken
together, these findings brought many authors to consider
MOH a bio-behavioral disorder [3–6]. Both the Fuh and
Radat studies found around 70 % of comorbidity between
MOH and substance abuse according to DSM-IVTR [4, 7].
Chronic exposure to addictive drugs is shown to be
associated with impairment of several neural networks,
including the fronto-striatal circuit, which involves the
prefrontal regions (including the dorsolateral cingulate
anterior and orbitofrontal areas), the limbic system
(amygdala, entorhinal cortex), and their projections to the
ventral striatum [8, 9].
The impairment of this circuit results in prefrontal cor-
tex impairment with a relative dominance of limbic regions
on behavior. As prefrontal regions no longer guide the
behavior toward controlled, rational and appropriate choi-
ces, limbic dominance causes a loss of control, and an
increase of impulsivity and semi-automatic actions [10].
In the meta-analysis on impaired decision-making in
addicts by Dom et al. [11], ten samples of patients with
various substance-use disorders exhibited impairment in
decision-making tasks relative to controls.
Some functional neuroimaging studies have investigated
the relationship between decision-making deficit and neu-
ral activation in different prefrontal areas. Both the fMRI
study by Paulus et al. [12] on meta-amphetamine addicts,
and the PET study by Bolla et al. [13] on cocaine abusers,
gave evidence that the decision-making deficit shown by
these samples compared to controls was consistent with
both orbitofrontal and dorsolateral prefrontal dysfunction.
A commonality between MOH and addiction arose from
a PET study by Fumal et al. [14], who found a persistent
hypometabolism of OFC 3 weeks before and 3 weeks after
the detoxification in MOH patients, suggesting that this
dysfunction might predispose certain migraineurs to MOH
and to relapse after the detoxification.
To our knowledge, while various studies have focused
on neuropsychology among those with substance-use dis-
orders, this is the first attempt to evaluate decision-making
in MOH patients through a neuropsychological task, the
Iowa gambling task (IGT).
Designed to assess patients with ventromedial lesions of
the prefrontal cortex, this computer-based card task is
known to evaluate the decision-making function [15].
The task consists of picking cards from four decks, each
of which can give unpredictable rewards or penalties. In
order to maximize an initial €2,000 loan of play money,
participants need to weigh short-term rewards against long-
term losses. In fact, the two risky decks (A and B) give
high rewards (€100), but total penalties outweigh them.
Otherwise, decks C and D give small but safer rewards
(50€). The optimal strategy is to integrate the value of these
varying rewards and penalties over time, avoiding the
short-term appeal of decks A and B in favor of the slower
gain from decks C and D. Performance on the gambling
task is evaluated through a net score, which corresponds to
the number of cards drawn from the advantageous decks
minus the number of cards drawn from the disadvantageous
ones. When negative, the net score expresses indeed a
decision-making deficit.
Wondering as to whether or not MOH patients would
show the same decision-making impairment previously
observed in addicts [11], we decided to compare the IGT
performances of MOH patients and healthy gender, and
age-matched controls. Furthermore, we investigated the
nature of this possible deficit, whether this was a temporary
consequence of medication overuse or a persistent feature.
Materials and methods
A sample of 50 patients, from 18 to 65 years of age with a
history of chronic migraine (i.e., present at least 15 days a
month on a regular basis for at least 3 months) and medi-
cation overuse (according to the latest ICHD-II criteria,
category 8.2.7) [16], were enrolled in the Headache Clinic
of the Neurological Institute Carlo Besta in Milan.
The first psychiatric evaluation included: Structured
Clinical Interview for DSM-IV TR Axis II Personality Dis-
orders, Hamilton Rating Scales for Anxiety and Depression,
migraine disability assessment (MIDAS) questionnaire and
severity of dependence scale (SDS).
The MIDAS questionnaire was developed to measure
the headache-related disability. It attempts to determine
how many days were affected in a patient’s life to the point
that he/she was unable to function in a usual way. Migraine
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disability assessment takes into account the last 3 months
when asking the questions [17, 18]. The SDS is a five-item
questionnaire, originally created to investigate opiate
dependence, recently used in people with primary and
secondary chronic headache to detect patterns of medica-
tion overuse and dependency-like behaviors [19, 20]. In
order to assess decision-making, both patients and healthy
age- and gender-matched controls underwent the Italian
version of the computer-based IGT [15].
The demographic, clinical, and psychopathological
characteristics of the patient population are described as
means and standard deviations, and reported in Table 1.
Twelve months later long-term monitoring was set up with
the same battery of tests in an outpatient regimen in order to
detect any relapse into medication overuse and dependence.
In the follow-up data elaboration, t test and Chi-square
were, respectively, used for comparison of continuous or
parametric variables (Mann–Whitney and Fisher exact test,
as appropriate). Type I and II errors were possible because
of the number of subjects and comparisons. In consideration
of the exploratory nature of the study, we referred to levels of
significance of P B 0.05, without operating any correction
for multiple comparisons.
Results
Of the 50 MOH patients included in the study, most
patients had continuous headache with superimposed epi-
sodes of acute headache (mean frequency of episodes per
month was 21.96 with 6.59 SD) and daily drug intake
(mean number of tablets per month was 31.04 with 22.51
SD). The overused medications were triptans alone (20
patients, 40 %), simple analgesics alone or in combination
with caffeine (26 patients, 52 %) and triptans plus anal-
gesics (six patients, 12 %).
Twenty-two patients (44 %) and 14 patients (28 %),
respectively, had a past and present Axis 1 psychiatric
diagnosis (anxiety disorder, major depressive disorder).
None fulfilled DSM-IVTR criteria for personality disorders.
The sample was characterized by high rates of disability
(mean MIDAS score was 69.60 with 49.18 SD) and severe
dependency-like behaviors due to anti-migraine drugs
(mean SDS score was 8.73 with 2.23 SD): 47 patients
(94 %) achieved an SDS score greater than or equal to 5,
the cut off for diagnosing the behavioral addiction for
painkillers [20].
Our sample of MOH patients showed a statistically
significant deficit in decision-making (mean net score on
IGT was -10.40 with 15.82 SD) compared to healthy
gender- and age-matched controls (independent sample
t test with t 8.08; df 79.6, sig two-tailed 0.000).
The dataset for the longitudinal study is now available
for the 20 patients: according to ICHD-II criteria [16], 13
of them (65 %) discontinued medication overuse after the
detoxification and restored an episodic migraine pattern; 7
patients (35 %) relapsed into MOH at 12-month follow-up,
despite the temporary resolution of medication overuse
soon after the detoxification.
Observing the clinical and psychopathological score
transition in the follow-up sample regardless of relapse
(Table 2), we found very significant decreases in MIDAS
score, pain intensity, frequency of episodes, and number of
tablets per month. In contrast to this global improvement,
the mean net score in IGT performance remained negative
(-7.70 with 16.92 SD), with a 1.00 statistical significance
in the paired samples t test, showing a persistent deficit in
decision-making.
Table 1 Demographic and
clinical features of medication-
overuse headache (MOH)
Baseline during withdrawal (N = 50)
Minimum Maximum Mean SD
AGE (years) 23.00 65.00 41.28 9.96
Migraine duration (years) 1.00 60.00 22.13 13.05
Medication overuse duration (years) 0.25 36.00 2.99 6.57
Frequency of episodes per month 15.00 30.00 21.96 6.59
Number of tablets per month 14.00 90.00 31.04 22.51
Pain intensity on VAS 3.00 10.00 7.80 1.64
HAM-A score 0.00 30.00 13.19 7.91
HAM-D score 0.00 39.00 12.60 7.56
Iowa gambling task net score -52.00 14.00 -10.40 15.82
Severity of dependence scale 4.00 13.00 8.73 2.23
MIDAS total score 7.00 270.00 69.60 49.18
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Discussion
The aim of this study was to show that migraineurs over-
using painkillers, although forced to cope with chronic pain,
often develop a behavioral addiction that might rise from
the same decision-making deficit often described in sub-
stance abuse [11]. Moreover, follow-up at 12 months
showed that, contrary to the global clinical and psycho-
pathological improvement observed in these patients,
decision-making was persistently impaired. Still, our data
confirm the OFC hypometabolism described by Fumal et al.
[14] in his PET study from a neuropsychological perspec-
tive. Taken together, this data show, in a preliminary but
promising way, that even a non-psychotropic drug depen-
dence can be associated with the fronto-striatal circuit
impairment and decision-making deficit traditionally
observed in different populations of addicts [8, 9, 11], and
more recently also in people with binge eating disorder and
pathological gambling. Thus, there is growing evidence in
considering MOH part of the addiction spectrum [21].
After attesting to a persistent decision-making deficit in
patients with MOH, yet recognizing the current small size of
our follow-up sample, further studies are needed to elucidate
the role of fronto-striatal circuit dysfunction. We believe that
the impairment of fronto-striatal networks might constitute a
psychobiological vulnerability [9] that, in this particular
condition, influences the clinical onset of medication over-
use and recurrent relapses in some patients with chronic
migraine. Therefore, clinicians will hopefully use the IGT as
a valid tool to identify chronic migraine patients at a higher
risk for medication overuse and relapse, who might poten-
tially require stricter monitoring.
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